Bank Of Montreal Glaukos Corp Transaction History

Bank Of Montreal

$197 Billion
Q2 2024

A detailed history of Bank Of Montreal transactions in Glaukos Corp stock. As of the latest transaction made, Bank Of Montreal holds 8,880 shares of GKOS stock, worth $1.25 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,880

Previous 13,581 34.61%

Holding current value

$1.25 Million

Previous $1.28 Million 17.97%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$89.48 - $118.35 $420,645 - $556,363	-4,701 Reduced 34.61%	8,880 $1.05 Million
Q1 2024 May 13, 2024	BUY	$76.4 - $96.33 $389,105 - $490,608	5,093 Added 60.0%	13,581 $1.28 Million
Q4 2023 Feb 08, 2024	BUY	$59.53 - $85.11 $11,846 - $16,936	199 Added 2.4%	8,488 $674,000
Q3 2023 Nov 01, 2023	BUY	$69.23 - $79.09 $2,976 - $3,400	43 Added 0.52%	8,289 $623,000
Q2 2023 Aug 02, 2023	SELL	$45.44 - $71.21 $795,518 - $1.25 Million	-17,507 Reduced 67.98%	8,246 $587,000
Q1 2023 Jun 13, 2024	BUY	$43.88 - $52.48 $591,677 - $707,640	13,484 Added 99.29%	27,065 $1.36 Million
Q4 2022 Feb 01, 2023	BUY	$40.82 - $57.75 $670,795 - $949,005	16,433 Added 176.32%	25,753 $1.12 Million
Q3 2022 Nov 10, 2022	SELL	$46.84 - $58.49 $5,948 - $7,428	-127 Reduced 1.34%	9,320 $531,000
Q2 2022 Aug 11, 2022	SELL	$34.86 - $63.77 $368,958 - $674,941	-10,584 Reduced 52.84%	9,447 $451,000
Q1 2022 May 12, 2022	BUY	$44.33 - $57.82 $110,160 - $143,682	2,485 Added 14.16%	20,031 $1.16 Million
Q4 2021 Feb 11, 2022	SELL	$40.27 - $56.99 $96,728 - $136,889	-2,402 Reduced 12.04%	17,546 $808,000
Q3 2021 Nov 12, 2021	SELL	$47.43 - $84.23 $6,545 - $11,623	-138 Reduced 0.69%	19,948 $987,000
Q2 2021 Aug 12, 2021	BUY	$73.06 - $97.7 $1.47 Million - $1.96 Million	20,086 New	20,086 $1.72 Million

Others Institutions Holding GKOS

# of Institutions

309

Shares Held

46.9M

Call Options Held

75.3K

Put Options Held

157K

View Full List

About GLAUKOS Corp

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $6.69B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

More about GKOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.

Account